Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

USFDA 483 to UCB Farchim Cites Deficienc

USFDA 483 / UCB Farchim SA/ June 2023 / Deficiencies in Method Transfer, Material receipt

Qvents
October 30, 2023

USFDA 483 to UCB Farchim Cites Gaps in D

Qvent post discusses the Regulatory guidances and Requirements for Electronic data controls and review, Data

Qvents
October 30, 2023